When was Accel Diagnostics founded?

Accel Diagnostics was founded in 2012 and raised its 1st funding round within a year of its incorporation.

Where is Accel Diagnostics located?

Accel Diagnostics is headquartered in Pittsburgh, United States.

Who is the current CEO of Accel Diagnostics?

Alberto Gandini of Accel Diagnostics.

How many employees does Accel Diagnostics have?

As of Aug 31, 2026, the latest employee count at Accel Diagnostics is 2.

Is Accel Diagnostics a funded company?

Accel Diagnostics is a funded company, having raised a total of $950K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 10, 2012.

When was the latest funding round of Accel Diagnostics?

Accel Diagnostics' latest funding was a $***** Seed round on Apr 25, 2013, with participation from 1 investor.

Where does Accel Diagnostics rank among its competitors?

Accel Diagnostics ranks 7th amongst 50 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Avery Digital, which secured $895K in Aug, 2025.

Who are the top competitors of Accel Diagnostics?

Accel Diagnostics' top competitors include microLIQUID, Noul and SpacePharma. Among them, Avery Digital secured the most recent funding round in August, 2025.

Accel Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Accel Diagnostics is a public company based in Pittsburgh (United States), founded in 2012 by Alberto Gandini. It operates as a Rapid, reliable, and affordable diagnostic lab testing services in Houston. Accel Diagnostics has raised $950K in funding. The company has 50 active competitors, including 10 funded and 6 that have exited. Its top competitors include companies like microLIQUID, Noul and SpacePharma.

Company Details

Rapid, reliable, and affordable diagnostic lab testing services in Houston. This diagnostic lab offers a wide range of testing services, including COVID-19, drug tests, wellness panels, STD panels, and general health tests. They provide advanced molecular testing with rapid and reliable results at affordable prices. Walk-ins are welcome, and online booking is available. The lab focuses on convenient and cost-effective solutions, offering transparent pricing and eliminating surprise bills. They cater to insured, uninsured, and high-deductible clients. Services include urine drug tests, annual check-up panels, and comprehensive STD testing. General health tests cover areas like blood count, metabolic count, lipid panel, and thyroid function. They also offer specialized tests for fungal infections, urinary tract infections, and wound infections. The lab is CLIA accredited, ensuring quality assurance and accurate results. They provide fast and private service with knowledgeable medical assistants.

Website: www.acceldx.com/
Social

Key Metrics

Founded Year

2012

Location

Pittsburgh, United States

Stage

Public

Total Funding

$950K in 4 rounds

Latest Funding Round

Seed, Apr 25, 2013, $*****

Investors

Innovation Works & 4 more

Ranked

7^th among 50 active competitors

Employee Count

2 as on Aug 31, 2026

Similar Companies

microLIQUID & 58 more

Exit Details

Public

View Accel Diagnostics' full profile

Accel Diagnostics has raised a total funding of $950K over 4 rounds. Its first funding round was on Feb 10, 2012. Its latest funding round was a Seed round on Apr 25, 2013 for $*****. 1 investor participated in its latest round. Accel Diagnostics has 5 institutional investors.

Here is the list of recent funding rounds of Accel Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 25, 2013	1325017	Seed	1817057	2752382	4124878	4182698
Sep 01, 2012	6461466	Angel	9198077	2309405	4874551	3533496
Jun 08, 2012	9971095	Seed	6163491	4323327	6821279	Swartz Center for Entrepreneurship at Carnegie Mellon University

Access funding benchmarks and valuations. Sign up today!

View details of Accel Diagnostics's funding rounds and investors

The founders of Accel Diagnostics is Alberto Gandini.

Here are the details of Accel Diagnostics' key team members:

Alberto Gandini: Co-Founder & CEO of Accel Diagnostics.

View details of Accel Diagnostics's Founder profiles and Board Members

Accel Diagnostics' employee count trend

Accel Diagnostics has 2 employees as of Aug 26. Here is Accel Diagnostics's employee count trend over the years:

Employee count trend for Accel Diagnostics

Uncover Accel Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Accel Diagnostics include microLIQUID, Noul and SpacePharma. Here is the list of Top 10 competitors of Accel Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	microLIQUID 2008, Bilbao (Spain), Acquired	Specializes in microfluidics	-	Europa, Orza	48/100
2nd	Noul 2015, Yongin si (South Korea), Public	AI-based digital microscope platform for blood analysis	-	Ulmer Investments	45/100
3rd	SpacePharma 2012, Herzliya (Israel), Series A	Provider of microgravity research solutions for researchers, institutes, and commercial companies	$5M	State of Mind Ventures, EIC Fund & 2 others	40/100
4th	ACXEL 2016, Foshan (China), Series A	Provider of microfluidic technology and solutions for life sciences industries	-	Winsdom Capital, Luxin Venture Capital Group ... & 4 others	40/100
5th	Axbio 2016, Shenzhen (China), Series B	Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI	$200M	Yunfeng Capital, MSA Capital & 7 others	39/100
6th	Micronit 1999, Enschede (Netherlands), Funding Raised	Microfluidic design and manufacturing	-	EIC Fund, Oost NL & 1 others	36/100
7th	Accel Diagnostics 2012, Pittsburgh (United States), Public	Rapid, reliable, and affordable diagnostic lab testing services in Houston	$950K	Innovation Works, CMU & 3 others	35/100
8th	Fluxus 2016, Sunnyvale (United States), Funding Raised	Provider of ultrasensitive bioanalysis systems and solutions	-	HHS, GHIT Fund	35/100
9th	Finnadvance 2018, Oulu (Finland), Seed	Developer of microfluidics and microtechnology solutions for drug development	$1.9M	Athensmed, Voima Ventures & 6 others	33/100
10th	Avery Digital 2020, Iceland, Funding Raised	Developer of CMOS chips to help in research and development for bioengineers	-	Social Impact Capital, HHS	33/100